<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ramspek CL</submitter><funding>UK National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands</funding><funding>National Institute for Health Research School for Primary Care Research</funding><funding>Dutch Kidney Foundation</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NIHR or the Department of Health and Social Care</funding><funding>Center for Innovative Medicine (CIMED) and ALF Medicin</funding><pagination>615-625</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9082803</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>51(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>External validation of prognostic models is necessary to assess the accuracy and generalizability of the model to new patients. If models are validated in a setting in which competing events occur, these competing risks should be accounted for when comparing predicted risks to observed outcomes.&lt;h4>Methods&lt;/h4>We discuss existing measures of calibration and discrimination that incorporate competing events for time-to-event models. These methods are illustrated using a clinical-data example concerning the prediction of kidney failure in a population with advanced chronic kidney disease (CKD), using the guideline-recommended Kidney Failure Risk Equation (KFRE). The KFRE was developed using Cox regression in a diverse population of CKD patients and has been proposed for use in patients with advanced CKD in whom death is a frequent competing event.&lt;h4>Results&lt;/h4>When validating the 5-year KFRE with methods that account for competing events, it becomes apparent that the 5-year KFRE considerably overestimates the real-world risk of kidney failure. The absolute overestimation was 10%age points on average and 29%age points in older high-risk patients.&lt;h4>Conclusions&lt;/h4>It is crucial that competing events are accounted for during external validation to provide a more reliable assessment the performance of a model in clinical settings in which competing risks occur.</pubmed_abstract><journal>International journal of epidemiology</journal><pubmed_title>Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models.</pubmed_title><pmcid>PMC9082803</pmcid><funding_grant_id>16OKG12</funding_grant_id><funding_grant_id>SPCR-142</funding_grant_id><pubmed_authors>Teece L</pubmed_authors><pubmed_authors>Snell KIE</pubmed_authors><pubmed_authors>van Diepen M</pubmed_authors><pubmed_authors>van Smeden M</pubmed_authors><pubmed_authors>Evans M</pubmed_authors><pubmed_authors>Ramspek CL</pubmed_authors><pubmed_authors>Riley RD</pubmed_authors><pubmed_authors>van Geloven N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models.</name><description>&lt;h4>Background&lt;/h4>External validation of prognostic models is necessary to assess the accuracy and generalizability of the model to new patients. If models are validated in a setting in which competing events occur, these competing risks should be accounted for when comparing predicted risks to observed outcomes.&lt;h4>Methods&lt;/h4>We discuss existing measures of calibration and discrimination that incorporate competing events for time-to-event models. These methods are illustrated using a clinical-data example concerning the prediction of kidney failure in a population with advanced chronic kidney disease (CKD), using the guideline-recommended Kidney Failure Risk Equation (KFRE). The KFRE was developed using Cox regression in a diverse population of CKD patients and has been proposed for use in patients with advanced CKD in whom death is a frequent competing event.&lt;h4>Results&lt;/h4>When validating the 5-year KFRE with methods that account for competing events, it becomes apparent that the 5-year KFRE considerably overestimates the real-world risk of kidney failure. The absolute overestimation was 10%age points on average and 29%age points in older high-risk patients.&lt;h4>Conclusions&lt;/h4>It is crucial that competing events are accounted for during external validation to provide a more reliable assessment the performance of a model in clinical settings in which competing risks occur.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T20:21:56.257Z</modification><creation>2025-04-04T20:21:56.257Z</creation></dates><accession>S-EPMC9082803</accession><cross_references><pubmed>34919691</pubmed><doi>10.1093/ije/dyab256</doi></cross_references></HashMap>